New Study Could Provide Potential Drug Targets for Alzheimer’s

In a new study, a process called Axon Myelination may help offer potential new drug targets for Alzheimer’s.

According to a study, certain genes in the brain cells of Alzheimer’s patients show distinctive cellular paths. Researchers said that this study could provide them with new drug targets for Alzheimer’s.

Researchers said, that this study has opened up avenues to understand Alzheimer’s better and have a more in depth view of the processes that are altered during Alzheimer’s in the human brain.